Fidus Investment continues to outperform peers by effectively navigating lower base rates and maintaining strong portfolio quality despite macro uncertainty. Their latest quarter showed impressive NAV growth, increased first-lien debt exposure, and a decline in non-accruals, highlighting prudent portfolio management. FDUS maintains a strong balance sheet with low leverage and ample liquidity, supporting dividend safety even if base rates decline further.

The U.S. government's new stake in Intel is making some investors nervous that President Donald Trump's deal heralds an era of government meddling in private industry, particularly as the arrangement followed Trump's call for the resignation of the computer chip maker's CEO.

Stability is at the top of the list of traits investors look for in dividend stocks, regardless of the sector or industry. The go-to dividend plays of long-term buy-and-hold strategists are not flashy companies or those in red-hot industries, but rather "boring" firms with a proven track record of consistency, even in difficult markets or economic climates.

SAN DIEGO, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Ventyx Biosciences, Inc. (Nasdaq: VTYX) (“Ventyx”, “Company”), a clinical-stage biopharmaceutical company focused on developing innovative oral therapies for patients with autoimmune, inflammatory, and neurodegenerative diseases, today announced that Company executives will participate in the following upcoming investor conferences: 2025 Wells Fargo Healthcare Conference Location: Boston, MADate: Friday, September 5, 2025Time: 11:00-11:35 AM EDT Morgan Stanley 23 rd Annual Global Healthcare Conference Location: New York, NYDate: Monday, September 8, 2025 H.C. Wainwright 27th Annual Global Investment Conference Location: New York, NYDate: Monday, September 8, 2025 A webcast of the Wells Fargo presentation will …

EDINBURG, Va., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Shenandoah Telecommunications Company (“Shentel”) (Nasdaq: SHEN), a leading provider of broadband services, is currently upgrading its network in Radford, Virginia, with 100% fiber-to-the-home internet service.

PBW, QCLN, CNRG, and HAIL have been hovering around 52-week highs as clean energy regulations, Ford's EV plan, Powell's rate cut hints and Tesla rally sparked momentum.

HOUSTON , Aug. 27, 2025 /PRNewswire/ -- Harvest Midstream ("Harvest") today announced the signing of a purchase and sale agreement with MPLX LP (NYSE: MPLX) for the acquisition of an extensive natural gas gathering and processing network in the Uinta and Green River basins across Wyoming, Utah, and Colorado for $1 billion. The transaction is expected to close in the fourth quarter of 2025 and marks a significant milestone in Harvest's continued evolution into one of the nation's leading privately held midstream companies.

Easy-to-use tail wrap and sensor gives riders and trainers insights into their horse's health and fitness OLATHE, Kan. , Aug. 27, 2025 /PRNewswire/ -- Garmin (NYSE: GRMN) today announced the Blaze™ equine wellness system , a tail wrap and sensor specifically designed to help riders, horse owners and trainers monitor their horse's health and fitness so they can make more informed decisions about their well-being and training.

WALTHAM, Mass., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD) today announced that it will present at the following investor conferences: Cantor Global Healthcare Conference 2025 Fireside Chat Date: Wednesday, September 3, 2025Fireside Chat Time: 2:10 PM ETLocation: New York, NY H.C.

REHOVOT, Israel, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Purple Biotech Ltd. (“Purple Biotech” or “the Company”) (NASDAQ/TASE: PPBT), a clinical-stage company developing first-in-class therapies that seek to overcome tumor immune evasion and drug resistance, today announced that the Company's CEO, Gil Efron will participate in a fireside chat and 1x1 investor meeting at the H.C. Wainwright 27th Annual Global Investment Conference, being held September 8-10, 2025.

TOKYO, Aug. 27, 2025 (GLOBE NEWSWIRE) -- CTW Cayman (Nasdaq: CTW) (“CTW” or “the Company”), a leading game platform company providing global access to web-based games through its flagship HTML5 platform, G123.jp, which showcases a diverse selection of free-to-play games inspired by popular Japanese animations, announced today that management will participate in the Lake Street Capital Markets Best Ideas Growth (BIG9) Conference taking place in New York City on September 11, 2025. Management will conduct one-on-one meetings throughout the day.

ANCHORAGE, Alaska , Aug. 27, 2025 /PRNewswire/ - U.S. GoldMining Inc. (NASDAQ: USGO) ("U.S. GoldMining" or the "Company") is pleased to announce that it is well underway with exploration at its 100% owned Whistler Gold-Copper Project (the "Whistler Project" or "Project") for the 2025 field season in Alaska. The program is focused on targeting continued growth through developing new drill targets at the Whistler Orbit and Muddy Creek prospect areas.

SALT LAKE CITY--(BUSINESS WIRE)--ReposiTrak (NYSE:TRAK), the world's largest food traceability and regulatory compliance network, leveraging its established inventory management and out-of-stock reduction SaaS platform, is proud to announce the addition of 28 deli, cheese and antipasti suppliers to the queue joining the ReposiTrak Traceability Network® (RTN). These companies will efficiently exchange intricate, FDA-required Key Data Elements (KDEs) for each Critical Tracking Event (CTE) in thei.

MENOMONEE FALLS, Wis.--(BUSINESS WIRE)--Kohl's Corporation (NYSE:KSS) today reported results for the second quarter ended August 2, 2025. Net sales decreased 5.1% and comparable sales decreased 4.2% Gross margin increased 28 basis points Diluted earnings per share (“EPS”) of $1.35 and adjusted diluted EPS of $0.56 (a) Raises full year 2025 financial outlook Michael Bender, Kohl's Interim Chief Executive Officer, said “Kohl's second quarter performance is a testament to the progress we are makin.

TORONTO--(BUSINESS WIRE)--Canada Goose Holdings Inc. (NYSE, TSX: GOOS) today announced that it will participate in the Goldman Sachs 32nd Annual Global Retailing Conference being held at the Conrad New York Downtown hotel in New York on September 3, 2025. We will host a fireside chat presentation at 3:15 pm ET and participate in one-on-one meetings. Beth Clymer, President, Chief Operating Officer and Neil Bowden, Chief Financial Officer will attend the conference. The fireside chat presentation.

BOSTON--(BUSINESS WIRE)--Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK pathway-driven cancers, today announced that its management team is scheduled to participate and present at the following investor conferences in September: Cantor Global Healthcare Conference 2025: Fireside chat on Wednesday, September 3 at 3:55 pm ET H.C. Wainwright 27th Annual Global Investment Conference: Fireside chat on Monday, September 8.

WATERTOWN, Mass., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of oral small molecule degrader medicines for immunological diseases, today announced that the Company will participate in fireside chats at the following upcoming investor events:

STAMFORD, Conn., Aug. 27, 2025 (GLOBE NEWSWIRE) -- The Lovesac Company (Nasdaq: LOVE) ("Lovesac" or the "Company"), the Designed for Life home and technology brand best known for its Sactionals, The World's Most Adaptable Couch, today announced that Alan Boehme has been appointed to the Board of Directors, effective August 27, 2025.

NEW YORK, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today announced that it will participate in the following upcoming investor conferences in September:

WALTHAM, Mass., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Sionna Therapeutics, Inc. (Nasdaq: SION), a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (CF) by developing novel medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator (CFTR) protein, today announced that management will participate in fireside chats at the following upcoming investor events: